WO2004012701A3 - Nouveau contenant polymere enterique robuste dependant du ph, ameliore par rapport aux formes posologiques existantes - Google Patents

Nouveau contenant polymere enterique robuste dependant du ph, ameliore par rapport aux formes posologiques existantes Download PDF

Info

Publication number
WO2004012701A3
WO2004012701A3 PCT/IN2003/000263 IN0300263W WO2004012701A3 WO 2004012701 A3 WO2004012701 A3 WO 2004012701A3 IN 0300263 W IN0300263 W IN 0300263W WO 2004012701 A3 WO2004012701 A3 WO 2004012701A3
Authority
WO
WIPO (PCT)
Prior art keywords
enteric
novel
dosage forms
improvement over
over existing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2003/000263
Other languages
English (en)
Other versions
WO2004012701A2 (fr
Inventor
Ajit Singh
Meena Parashuraman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scitech Centre
Original Assignee
Scitech Centre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scitech Centre filed Critical Scitech Centre
Priority to AU2003274683A priority Critical patent/AU2003274683A1/en
Publication of WO2004012701A2 publication Critical patent/WO2004012701A2/fr
Publication of WO2004012701A3 publication Critical patent/WO2004012701A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne de nouveaux contenants polymères entériques robustes dépendants du pH, telles des capsules dures, et un procédé de fabrication de ceux-ci. Les contenants polymères sont caractérisés en ce qu'ils présentent une élasticité améliorée grâce à une proportion adéquate de plastifiants dans la composition de l'enveloppe de la capsule, plutôt que dans la composition d'enrobage.
PCT/IN2003/000263 2002-08-02 2003-08-01 Nouveau contenant polymere enterique robuste dependant du ph, ameliore par rapport aux formes posologiques existantes Ceased WO2004012701A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003274683A AU2003274683A1 (en) 2002-08-02 2003-08-01 NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US691/MUM/2002 2002-08-02
US6912002 2002-08-02

Publications (2)

Publication Number Publication Date
WO2004012701A2 WO2004012701A2 (fr) 2004-02-12
WO2004012701A3 true WO2004012701A3 (fr) 2004-03-25

Family

ID=36118207

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2003/000263 Ceased WO2004012701A2 (fr) 2002-08-02 2003-08-01 Nouveau contenant polymere enterique robuste dependant du ph, ameliore par rapport aux formes posologiques existantes

Country Status (2)

Country Link
AU (1) AU2003274683A1 (fr)
WO (1) WO2004012701A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1545475T3 (da) * 2002-10-01 2014-07-28 Banner Pharmacaps Inc Enterisk sammensætning til fremstillingen af blød kapselvæg
US9254270B2 (en) 2002-10-01 2016-02-09 Banner Life Sciences Llc Enteric soft capsules
WO2009062356A1 (fr) * 2007-11-13 2009-05-22 Shanghai Huiyuan Vegetal Capsule Co., Ltd Enveloppe de gélule dure, gastrorésistante et sans gélatine et procédé de préparation de celle-ci
GB0918590D0 (en) * 2009-10-22 2009-12-09 Ayanda As Composition
JP6397813B2 (ja) 2012-05-02 2018-09-26 キャプシュゲル・ベルジウム・エヌ・ヴィ ヒドロキシプロピルメチルセルロースアセテートスクシネート（ｈｐｍｃａｓ）の水性分散液
JP6480327B2 (ja) * 2012-06-14 2019-03-06 マイクロベンション インコーポレイテッドＭｉｃｒｏｖｅｎｔｉｏｎ， Ｉｎｃ． ポリマー治療組成物
US9980916B2 (en) * 2013-03-15 2018-05-29 Patheon Softgels, Inc. Non-gelatin enteric soft capsules
EP3065720A1 (fr) 2013-11-04 2016-09-14 Capsugel Belgium NV Méthodes et systèmes pour une biodisponibilité améliorée de principes pharmaceutiques actifs comprenant de l'ésoméprazole
CA2950203C (fr) 2014-06-20 2019-09-03 Banner Life Sciences Llc Compositions de capsules enteriques molles
PL239878B1 (pl) * 2016-03-30 2022-01-24 Gdanski Univ Medyczny Wodna kompozycja oraz sposób wytwarzania dojelitowych elastycznych filmów do sporządzania kapsułek z wodnej kompozycji oraz dojelitowy elastyczny film do sporządzania kapsułek miękkich

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138013A (en) * 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules
EP0056825A1 (fr) * 1981-01-22 1982-08-04 Capsugel A.G. Procédé pour la préparation de capsules pharmaceutiques ayant des propriétés entériques
DE3222476A1 (de) * 1982-06-15 1983-12-15 Warner-Lambert Co., 07950 Morris Plains, N.J. Magensaftresistente weichgelatinekapseln und verfahren zu ihrer herstellung
JPS6216432A (ja) * 1985-07-05 1987-01-24 Shin Etsu Chem Co Ltd 腸溶性コ−テイング用組成物
WO2001024780A2 (fr) * 1999-10-01 2001-04-12 Natco Pharma Limited Composition pharmaceutique amelioree et procede de fabrication

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138013A (en) * 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules
EP0056825A1 (fr) * 1981-01-22 1982-08-04 Capsugel A.G. Procédé pour la préparation de capsules pharmaceutiques ayant des propriétés entériques
DE3222476A1 (de) * 1982-06-15 1983-12-15 Warner-Lambert Co., 07950 Morris Plains, N.J. Magensaftresistente weichgelatinekapseln und verfahren zu ihrer herstellung
JPS6216432A (ja) * 1985-07-05 1987-01-24 Shin Etsu Chem Co Ltd 腸溶性コ−テイング用組成物
WO2001024780A2 (fr) * 1999-10-01 2001-04-12 Natco Pharma Limited Composition pharmaceutique amelioree et procede de fabrication

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 011, no. 193 (C - 430) 20 June 1987 (1987-06-20) *

Also Published As

Publication number Publication date
AU2003274683A1 (en) 2004-02-23
WO2004012701A2 (fr) 2004-02-12
AU2003274683A8 (en) 2004-02-23

Similar Documents

Publication Publication Date Title
ZA200203867B (en) alpha-Amino acids compounds, a process for their preparation and pharmaceutical compositions containing them.
MXPA05003524A (es) Preparaciones entericas.
WO2006125620A3 (fr) Noyaux et microcapsules pouvant etre administres par voie parenterale et leur procede de fabrication
CA2376811A1 (fr) Additifs granules, revetus de polymeres et contenant des enzymes, destines a des aliments pour animaux, et procede de production correspondant
ZA200202525B (en) α-amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them.
AU2003286994A1 (en) Modified release pharmaceutical composition
WO2004012701A3 (fr) Nouveau contenant polymere enterique robuste dependant du ph, ameliore par rapport aux formes posologiques existantes
MY139206A (en) Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt
WO2001034835A3 (fr) Procede de production de biopolymeres a proprietes modifiees
ZA200105394B (en) Diphenylurea compounds, a process for their preparation and pharmaceutical composition containing them.
WO2004043383A3 (fr) Nouvelle cible pour la therapie angiogenique et anti-angiogenique
WO2006085227A3 (fr) Microcapsules et emulsions contenant de la gelatine a faible degre bloom et procedes de fabrication et d'utilisation correspondants
ID27377A (id) Bentuk baru dari irbesartan, proses pembuatannya dan komposisi farmasi yang mengandung irbesartan tersebut
PL339892A1 (en) Container closure, method of making closure as well package closure container
AU2002231219A1 (en) Water soluble, randomly substituted partial n-, partial o-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
WO2006034420A3 (fr) Composition de biomateriau polyvalente
CA2419314A1 (fr) Preparation de risperidone
WO2003087050A3 (fr) Sel de perindopril et les compositions pharmaceutiques qui le contiennent
WO2005012356A3 (fr) Gelules de gelatine
WO2008099835A1 (fr) Bande de soudage pour capsules dures contenant du peg encapsulé
WO2003099192A3 (fr) Alcanols bi-aromatiques
WO2007072495A3 (fr) Comprimes enrobes a liberation controlee caracterises par une retention gastrique prolongee
WO2005046727A3 (fr) Capsules gelatineuses molles renfermant de l'ibuprofene
WO2008114656A1 (fr) Préparation pulvérulente de lipase, procédé de fabrication de celle-ci et son utilisation
WO2006053564A3 (fr) Stabilisation de granules comprenant des composes actifs

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP